Immtech Pharmaceuticals, Inc.

Management Team

Eric L. Sorkin
Chairman and Chief Executive Officer

Mr. Sorkin has 25 years of making strategic investments and business development. He has been
affiliated with Immtech since 1998, when he became an investor. In 2000, Mr. Sorkin became a director
for the Company, and more recently was appointed Chairman of the Board and CEO. Mr. Sorkin began
his career on Wall Street in 1982 working at Dean Witter, which is now a subsidiary of Morgan Stanley,
and from an entry-level position, he was promoted to Managing Director within six years. He was among
the core group of professionals at the firm, which developed the firm’s investment portfolio with assets
of over USD $3 billion. Mr. Sorkin was responsible for investment selection, negotiations, transaction and
financial structuring, debt placement, and asset management. Mr. Sorkin was Officer of over 20 public
investment partnerships with investment funds totaling over USD $1 billion. In 1993, Mr. Sorkin created
his own investment firm and began making private equity investments in the U.S. and in China. Mr. Sorkin
graduated from Yale University with a B.A. in Economics.

Cecilia Chan
Vice Chairman
- BIO

Gary C. Parks
Secretary, Treasurer and Chief Financial Officer
- BIO

Carol Ann Olson, M.D., PhD
Senior Vice President of Pharmaceutical Development and Chief Medical Officer
- BIO

Norman A. Abood, PhD
Senior Vice President, Discovery Programs
- BIO

Daniel M. Schmitt
Senior Vice President, Licensing and Commercial Development
- BIO